EPS Bio (4183.TWO) monthly revenue, September 2026

EPS Bio reported revenue of NT$0.03bn for September 2026, up 8.0% from the previous month and down 31.0% from a year earlier. Year-to-date revenue was NT$0.26bn, down 31.4% year on year. It ranked 139 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.

中文版

MonthRevenue NT$bnMoM %YoY %
September 20260.038.0-31.0